Dr. Greene is a General Partner at MPM Capital, based in the San Francisco office. He joined MPM in 2002 and focuses on biopharmaceutical and medical device investments. Current and prior investments include Alsius, Inc, Archus Orthopedics, Barrier Therapeutics(BTRX), Cotherix (sold to Actellion), Endogastric Solutions, Idun (sold to Pfizer), Intercell AG (Vienna stock exchange, ICLL), Neovista, Inc, Quatrx Pharmaceuticals, and Synergia Pharma. Dr. Greene’s experience prior to MPM includes biotechnology drug development, academic research and the practice of medicine. From 1998-2002 he served as a Senior Clinical Scientist and Epidemiologist at Genentech where his responsibilities in clinical strategy, trial design and management, regulatory interactions and safety monitoring spanned projects and products in several therapeutic areas. From 1991-1998, Dr. Greene was at Yale Medical School where he trained in Internal Medicine and Diagnostic Radiology, taught medicine and did clinical research. Dr. Greene has been a Robert Wood Johnson Clinical Scholar at Yale (clinical epidemiology), a Howard Hughes Medical Institute Research Scholar at the NIH (neurobiology), and has done research at the Massachusetts General Hospital and the University of Padua, Italy. He has published widely, taught and practiced medicine, and has managed a private medical practice. He has been awarded the Henry Christian Award for outstanding research from the American Federation of Clinical Research and is a member of the American College of Physicians and the Society for Clinical Epidemiology and Health Care Research. He received a BA degree from Wesleyan University and an MD degree from UCSF, where he is currently an Assistant Professor of Medicine.
